OpenEvidence closed a $735M Series D in January 2026 to push its physician-facing clinical search across more than 40% of US doctors, the largest deployment in the category. Ambience Healthcare reached $243M Series C as the leading ambient-scribe product against Suki AI's $70M and a still-private Heidi AI. Tempus and Recursion straddle this category and ai-drug-discovery, while Lunit and Harrison.ai dominate AI radiology in oncology and chest imaging respectively. Glass Health and K Health build clinical-decision-support layers on top of the EHR, and Color Health rebuilt cancer-care navigation around an AI copilot. FDA 510(k) clearances for AI-as-medical-device are now flowing at a record pace.
CATEGORY
Best AI Medical Tools
54 tools compared · 2026
Ambient scribes, clinical search, and FDA-cleared imaging tools deployed at the point of care
54 ai medical startups tracked, with the largest concentration in US. Total tracked funding: $5.1B.
Tracked
54
Total Raised
$5.1B
Countries
11
Active Deals
0
1 
Aidoc Tel Aviv, Israel $500M 2 
Atropos Health New York, United States $53.8M 3 
Delfina San Francisco, United States $22.3M 4 
CodaMetrix Boston, United States $95M 5 
Axiom Bio San Francisco, United States $15M 6 
Treeline Biosciences Stamford, US $1.1B 7 
OpenEvidence San Francisco, US $735M 8 
Andy AI San Francisco, United States — 9 
Rad AI San Francisco, United States — 10 
SmarterDx New York, United States — 11 
Color Health US $482M 12 
Neko Health Stockholm, SE $325M
Funding by year — AI Medical
2020 → 2026Market overview
Key trends 2026
- Ambient scribes reach saturation pricing. Suki, Ambience, and Heidi compete at $200-400/clinician/mo, down from $600+ a year ago.
- OpenEvidence becomes the doctor-facing search default. $735M Series D funds outpaces any UpToDate-replacement attempt before it.
- FDA AI/ML 510(k) clearances accelerate. 2024-2026 device list growth tracks above 200/year, vs ~30/year pre-2020.
Benchmarks vs global
Largest 2026 round
$735M (OpenEvidence Series D)
vs $243M Ambience Series C ↑
Ambient scribe seat price
$200-400/mo
vs $600+/mo in 2024 ↓
FDA AI/ML device clearances
200+/yr (2024-26)
vs ~30/yr pre-2020 ↑
Top countries
By startup countStage breakdown
Latest round typeTop investors backing AI Medical
See all →General Catalyst
7 deals
BC
Breyer Capital
4 deals
EC
Emerson Collective
4 deals
TC
Transformation Capital
3 deals
Viking Global Investors
3 deals
MC
March Capital
3 deals
SV
Story Ventures
3 deals
TR
T. Rowe Price
3 deals
Atomico
3 deals
Khosla Ventures
3 deals
Sequoia Capital
3 deals
S
SemperVirens
2 deals
FAQ
Frequently asked
How is ai-medical different from ai-drug-discovery?
AI-medical covers point-of-care clinical tools — scribes, decision support, imaging, search (OpenEvidence, Ambience, Suki, Lunit). AI-drug-discovery covers preclinical R&D — molecular generation, target ID, protein folding (Recursion, Insilico, Chai). A few firms (Tempus, Recursion) operate in both.
Which AI medical startup has raised the most?
OpenEvidence leads at $735M total funding after its January 2026 Series D, focused on a clinical search product used by US physicians. Ambience Healthcare follows at $243M Series C for ambient documentation, then Suki AI at $70M.
Are these tools FDA-cleared?
It depends on intended use. Diagnostic imaging products (Lunit, Harrison.ai modules, NIRAMAI) carry FDA 510(k) or CE Mark clearance. Documentation and search tools (Ambience, Suki, OpenEvidence) typically operate as non-device clinical software, which has lighter regulatory requirements.
Recent rounds in AI Medical
All rounds →| Date | Startup | Round | Amount |
|---|---|---|---|
| May 2026 | NVision | Series B | $55M |
| Apr 2026 | Aidoc | Series E | $150M |
| Mar 2026 | XCath | Series C | $30M |
| Mar 2026 | Procode AI | Seed | $4M |
| Jan 2026 | OpenEvidence | Series D | $250M |
| Jan 2026 | Surgerii Robotics | Series D | $100M |
| Dec 2025 | Valerie Health | Series A | $30M |
| Dec 2025 | a2z Radiology AI | Seed | $4.5M |
All AI Medical startups
Page 2Capstan Medical
Robotic and catheter-delivered implants for minimally invasive heart valve repair
Raised
$184M
Stage
S-C
XCath
Next-generation endovascular robotics and steerable neurovascular guidewires
Raised
$92M
Stage
S-C
VideaHealth
FDA-cleared dental AI that detects disease on X-rays in real time
Raised
$60M
Stage
S-B
Kintsugi
Voice biomarker AI to detect depression and anxiety from speech
Raised
$28M
Stage
S-A
NVision
Quantum-enhanced MRI that images disease metabolism in real time
Raised
$120M
Stage
S-B
Upheal
AI-native EHR and clinical notes for mental health therapists
Raised
$14.3M
Stage
S-A
Quibim
AI-powered imaging biomarkers for precision medicine
Raised
$50M
Stage
S-A
Valar Labs
AI-powered precision oncology tests that predict how individual cancer patients will respond
Raised
$26M
Stage
S-A
Suki AI
VerifiedAI voice assistant for clinicians
Raised
$165M
Stage
S-D
Triomics
Oncology-specific AI agents that turn unstructured EHRs into structured cancer data
Raised
$36M
Stage
S-B
Cerebriu
Real-time AI triage and protocol optimization for brain MRI
Raised
$19M
Stage
S-A
Gestalt Diagnostics
AI-enabled digital pathology platform for cancer diagnosis
Raised
$7.5M
Stage
S-A
Qure.ai
Medical-imaging AI company whose algorithms read chest X-rays, head CT scans, and other
Raised
$123M
Stage
S-C
Barreleye
Korean medical AI startup developing ultrasound-based diagnostic solutions powered by deep
Raised
$10M
Stage
S-A
Eko Health
Makes FDA-cleared digital stethoscopes paired with AI that helps clinicians detect heart and
Raised
$41M
Stage
S-D
Acurion
San Diego precision oncology company developing AI-powered image analysis that extracts
Raised
$4.3M
Stage
Seed
Prenosis
Precision medicine company building AI-based diagnostics for acute and critical care
Raised
$60M
Stage
S-A
Suki
AI voice assistant for clinicians that uses generative AI to ambiently create clinical
Raised
$73M
Stage
S-D
Navina
Clinical AI company whose copilot transforms scattered healthcare data into actionable
Raised
$55M
Stage
S-C
Regard
Healthcare AI company that builds an AI co-pilot for physicians, automatically analyzing
Raised
$61M
Stage
S-B
Corti
Copenhagen-based healthcare AI company building specialized foundation models and a clinical
Raised
$60M
Stage
S-B
Aignostics
Berlin-based computational pathology company building AI foundation models that analyze tissue
Raised
$34M
Stage
S-B
Tortus
UK-based clinical AI company building an AI co-pilot, branded OSLER, that automates clinical
Raised
$4.2M
Stage
Seed
Lunit
Conquer cancer through cutting-edge AI for earlier detection and more precise oncology treatments.